Because the precise targeting of the CyberKnife System significantly reduces irradiation of surrounding healthy tissues, CyberKnife may be a treatment option for a wider range of lung cancer patients:
- Patients treated with conventional radiotherapy systems may be candidates for re-irradiation with the CyberKnife System, in the event of recurrence.
- Patients treated with the CyberKnife System may be candidates for re-treatment, in the event of recurrence.
- Additionally, patients treated with the CyberKnife System may sometimes be candidates for surgical interventions, in the event of recurrence.